Balloon-occluded retrograde transvenous obliteration
Balloon-occluded retrograde transvenous obliteration (B-RTO) is a medical procedure used primarily in the treatment of gastroesophageal varices. This technique was first developed in Japan in the 1980s and has since been adopted worldwide due to its high success rate and low complication rate.
Procedure[edit]
The B-RTO procedure involves the use of a balloon catheter to occlude a vein and a sclerosing agent to obliterate the varices. The procedure is performed under fluoroscopic guidance to ensure accurate placement of the catheter and sclerosing agent. The balloon is inflated to occlude the vein, and the sclerosing agent is then injected retrograde into the varices. This causes the varices to shrink and eventually disappear.
Indications[edit]
B-RTO is primarily indicated for the treatment of gastroesophageal varices that are refractory to other treatments, such as endoscopic band ligation and pharmacotherapy. It may also be used in patients with portal hypertension who are not candidates for surgical shunting.
Complications[edit]
While B-RTO is generally considered safe, complications can occur. These may include hemorrhage, infection, thrombosis, and pulmonary embolism. However, these complications are rare and can usually be managed effectively.
Efficacy[edit]
Numerous studies have demonstrated the efficacy of B-RTO in the treatment of gastroesophageal varices. It has been shown to be highly effective in obliterating varices and preventing rebleeding, with success rates often exceeding 90%.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian